From: The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada
Validation of PROM
HRQL PROM n (%)
Non-HRQL measure n (%)
Total n (%)
Not validated
20 (33)
15 (33)
35
Validateda
36 (60)
26 (58)
62
No reference given
4 (7)
4 (9)
8
Total
60
45
105 (p = 0.910)